Denice Torres - Aug 2, 2021 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, Attorney-in-Fact
Stock symbol
SURF
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/3/2021, 04:16 PM
Previous filing
Jul 8, 2021
Next filing
Oct 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +36K $0.00 36K Aug 2, 2021 Common Stock 36K $6.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest ratably over three years following July 6, 2021, so long as the grantee remains a director or other service provider of the Company on such dates.